
Intersect ENT, Inc. XENT
Country |
|
IPO year |
2014 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
32.7 M |
Market Cap[1] |
$ 955 M |
EBITDA (LTM) |
$ -71 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 1.35 | - | $ 21.8 M | Nasdaq Global Select Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Orthofix Medical
OFIX
|
$ 11.72 | -1.26 % | $ 464 M | Nasdaq Global Select Market,SPB | ||
|
LENSAR
LNSR
|
$ 5.56 | -8.4 % | $ 64 M | Nasdaq Capital Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
AxoGen
AXGN
|
$ 32.61 | 2.71 % | $ 1.5 B | Nasdaq Capital Market,SPB | ||
|
CONMED Corporation
CNMD
|
$ 36.56 | -0.19 % | $ 1.13 B | NYSE,SPB | ||
|
Penumbra
PEN
|
$ 334.17 | -0.41 % | $ 13 B | NYSE,SPB | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Electromed
ELMD
|
$ 24.7 | 0.86 % | $ 209 M | NYSE American | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Insulet Corporation
PODD
|
$ 225.5 | -0.7 % | $ 15.9 B | Nasdaq Global Select Market,SPB | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.7 | 3.3 % | $ 38.1 M | Nasdaq Capital Market | ||
|
Aethlon Medical
AEMD
|
$ 2.16 | -6.09 % | $ 3.37 M | Nasdaq Capital Market | ||
|
Profound Medical Corp.
PROF
|
$ 5.15 | -4.63 % | $ 180 M | Nasdaq Global Select Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Quanterix Corporation
QTRX
|
$ 3.82 | -3.05 % | $ 163 M | Nasdaq Global Select Market,SPB | ||
|
AdaptHealth Corp.
AHCO
|
$ 11.48 | 10.7 % | $ 1.55 B | Nasdaq Capital Market | ||
|
Myomo
MYO
|
$ 0.7 | -1.83 % | $ 29.3 M | NYSE American | ||
|
Nano-X Imaging Ltd.
NNOX
|
$ 2.4 | -1.64 % | $ 141 M | Nasdaq Global Select Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.91 | 4.83 % | $ 146 M | Nasdaq Global Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 15.91 | -3.4 % | $ 373 M | Nasdaq Global Select Market,SPB | ||
|
Outset Medical
OM
|
$ 3.53 | -2.35 % | $ 53.7 K | Nasdaq Global Select Market | ||
|
Inspire Medical Systems
INSP
|
$ 52.07 | -0.17 % | $ 1.53 B | NYSE,SPB | ||
|
Sintx Technologies
SINT
|
$ 2.57 | 0.78 % | $ 7.13 M | Nasdaq Capital Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.31 | -5.76 % | $ 53.3 M | Nasdaq Global Select Market | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Sensus Healthcare
SRTS
|
$ 3.96 | -3.65 % | $ 64.7 M | Nasdaq Capital Market | ||
|
InspireMD
NSPR
|
$ 1.79 | 3.47 % | $ 115 M | NYSE American | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
NuVasive
NUVA
|
- | - | $ 2.07 B | Nasdaq Global Select Market,SPB | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.